1 / 31

VASCULAR ENDOTHELIUM & ITS FUNCTIONAL ASSESSMENT

VASCULAR ENDOTHELIUM & ITS FUNCTIONAL ASSESSMENT. Upa Kukongviriyapan Department of Physiology, Faculty of Medicine Khon Kaen University, Thailand. B.Sc. Experimental Pathology Queen Mary’s School of Medicine and Dentistry The Royal London Hospital October 12, 2005. Topic Contents.

auryon
Download Presentation

VASCULAR ENDOTHELIUM & ITS FUNCTIONAL ASSESSMENT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VASCULAR ENDOTHELIUM &ITSFUNCTIONAL ASSESSMENT Upa Kukongviriyapan Department of Physiology, Faculty of Medicine Khon Kaen University, Thailand. B.Sc. Experimental Pathology Queen Mary’s School of Medicine and Dentistry The Royal London Hospital October 12, 2005

  2. Topic Contents • Structure and functions of vascular endothelial cell. • The endothelial dysfunction. • The oxidant- stress induced endothelial dysfunction. • How to assess endothelial functions. • Summary

  3. The Normal Vascular Endothelium • Historically viewed as a passive • vascular lining.

  4. Vascular Endothelium • Many important roles to maintain vascular homeostasis: • Vascular tone regulation • VSMC proliferation • Inflammatory responses • Haemostasis • It produces and releases vasoactive, thromboregulatory and growth factor substances.

  5. Endothelial cell functions • Maintaining the vascular tone: Vasodilation and Vasoconstriction Tousoulis, et al., Heart 2005; 91: 353-358.

  6. Inflammation Proinflammatory Antiinflammatory Adhesion molecules Selectin-E, VCAM-1, ICAM-1, PECAM-1 Endothelial cell functions Functional targets Physiological action/Mediators Growth Stimulation Inhibition PDGF, FGF NO, PGI2, TGF IGF-1, ET, AII

  7. Endothelial cell functions Functional targets Physiological action/Mediators Haemostasis Prothrombotic Antithrombotic PAI-1 PGI2, TPA Calles-Escandon and Cipolla, Endocrine Rev 2001; 22: 36-52.

  8. Factors affecting vascular tone and structure

  9. “ An impairment of endothelium-dependent vasorelaxation caused by a loss of NO bioactivity in the vessel wall. Endothelial Dysfunction • pathological conditions • altered anticoagulant & • anti-inflammatory properties • impaired modulation of • vascular growth & • dysregulation of vascular • remodeling

  10. Xanthine oxidase, NADP/NADPH oxidase uncoulpled eNOS NO bioavailability Unifying model: Endothelial dysfunction to CVD

  11. How can we assess the endothelial function?

  12. Methods for exploring endothelial function.(Guerci et al., Diabetes Metab 2001; 27: 425-434.)

  13. Clinical Studies Supporting the Prognostic Value of Endothelial Vasomotor Function Testing.(Ganz, et al. Circulation 2003; 108: 2049-2053.) Patients with endothelial dysfunction had a far greater incidenceof adverse cardiovascular events in follow-up comparedwith patients with preserved endothelial function.

  14. Key points for evaluating ED. Tousoulis D, et al., Heart 2005; 91: 353-358.

  15. Evaluating Endothelial Function in HumansNon-invasive techniques • High resolution ultrasonography: Assessment of flow-mediated dilatation (FMD). • Strain-gauge plethysmography: Evaluation of forearm blood flow (FBF).

  16. Flow-mediated dilatation (FMD) • Is defined as an endothelium-dependent process that reflects the relaxation of a conduit artery when exposed to increased flow and, thereby, increased shear stress. • An impaired FMD response reflects endothelial dysfunction. • A temporary increase in shear stress can be induced by increasing the local blood flow, the so-called • “reactive hyperemia”. • An abrupt decrease in vascular resistance mediated by the EDNO caused FMD. Tousoulis D, et al., Heart 2005: 91: 553-558.

  17. The genesis of FMD Moens, et al., Chest 2005; 127: 2254-2263.

  18. Flow-mediated vasodilation (FMD)

  19. Equipment: Ultrasonic imaging of brachial artery diameter Measurement of vasodilation response by ultrasonic imaging of arterial diameter: • should be equipped withvascular software for2D imaging, color andspectral Doppler, aninternal ECG monitorand high frequency vascular transducerattached to a high-quality mainframe ultrasound. and • Noninvasive, simple, costly, widely available, need further • validation.

  20. Brachial Artery Flow-Mediated DilationBaseline5 MinutesPost-OcclusionBlood Pressure Cuff Occlusion – 1 Minute Release 3.6 mm 3.1 mm

  21. Forearm blood flow(Strain-gauge plethysmography) • Noninvasive, simple, reproducible and less observer dependent, need further validation. • The strain-gauge is attached to the upper forearm, and connected to plethysmographic device. . • FBF is measured by temporarily occluding the venous return (by a cuff inflated to 40 mmHg) and measured the slight swelling of the distal portion of the limb due to continued arterial inflow.

  22. Forearm blood flow(Strain-gauge plethysmography) • The initial rate of swelling represents the arterial inflow. • The technique evaluates the percentage change of flow from baseline to the maximum flow during reactive hyperaemia following a five minute ischaemia of the forearm. Tousoulis D, et al., Heart 2005: 91: 553-558.

  23. Sample window • The FBF is estimated by the gradient of the tangent to the curve • duringthe first cardiac cycles. • Result of forearm flow is expressed as ml/100 ml tiss/min or the • percent changes in flow.

  24. Timetable of FMD & FBF Tousoulis D, et al., Heart 2005; 91: 353-358.

  25. Application in clinical trials • Study design:Acute or long-term intervention trials. • Sample size:A crossover or a parallel- group design study. • Methodology:Select most reproducible results. • Evaluating precision of the technique. • Individual training in the principles and technical • aspect of Doppler ultrasonography and Strain-gauge • plethysmography.

  26. SUMMARY • Endothelial functional testing can be used as an indicator for vascular damage or vascular disease and also other diseases relating to oxidative stress conditions. • Reversal of endothelial dysfunction protects against progression of vascular disease.

  27. SUMMARY • Proposed new tests for evaluating endothelial function should be developed with optimal characteristics; • Cost-effective, reproducible and standardization. • Ability to predict risk and relationship to established tests of risk. • Useful as a screen for drug development. • Can identify individual patients. • Can predict a reduction in the risk of clinical events.

  28. QUESTIONS • What are the main functions of the vascular endothelial cell? • What is the endothelial dysfunction? How can it lead to the cardiovascular disease? • How can we evaluate the endothelial functions? • What are the key points for evaluating the endothelial dysfunction?

  29. The End For NowBut there is much more to learn!!!! Thank you!

More Related